Asthma, COPD, sleep apnea, infections, and environmental lung risks.
An article joins this feed when it matches these terms. Each one is also a search of its own.
This study aimed to investigate the advantages and applications of machine learning models in predicting the risk of allergic rhinitis (AR) in children aged 2â8, compared to traditional logistic regression. The study analyzed questionnaire data from... Uncover the latest and most…
Recently, I've been spending time in environments where many people smoke, and it suddenly reminded me of the past. Come to think of it, I used to smoke too. I started smoking when I was a university student and smoked…
Autism is a diverse group of conditions related to development of the brain. The World Health Organization estimates that as of 2021, 1 in 127 people globally had autism. Exact numbers for India are hard to come by, but up to 1.8-2 million children…
A new Courier Journal series examines how asthma inflicts a billion-dollar toll in Kentucky. Here's how we reported it. How we reported 'Breathless,' our investigation into asthma in Kentucky This summer, The Courier Journal examined how asthma inflicts a billion-dollar…
Presented by AJMC and Pharmacy Times Long-term tele-messaging was more effective than no messaging and short-term messaging for positive airway pressure use, and it was highly likely to be cost-effective with an acceptable willingness-to-pay threshold. Objectives: To evaluate the cost-effectiveness…
Presented by AJMC and Pharmacy Times Objectives: To measure adherence to inhaled corticosteroid (ICS) therapy using prescription claims and a patient survey, to identify local adverse events (LAEs) from the patient perspective and from medical records, and to evaluate the…
AstraZeneca PLC (AZN) Wednesday said the European Commission has approved Trixeo Aerosphere as a maintenance treatment for asthma in patients aged 12 and older who are not adequately controlled with medium-dose inhaled corticosteroid and long-acting beta2-agonist therapy. The approval is based…
Presented by AJMC and Pharmacy Times A Q&A With Reynold A. Panettieri Jr, MD Dr Panettieri: A recent focus in managing COPD has been an emphasis on reducing exacerbation frequency. This came about after data emerged showing that just a…
Presented by AJMC and Pharmacy Times A Q&A With Parth Rali, MD, FCCP, FASPR AJMC®: How is COPD definitively diagnosed in clinical practice, and how does this disease create a clinical burden on patients and caregivers? As with other…
Presented by AJMC and Pharmacy Times Patient education is critical for self-monitoring of COPD disease progression. Jeffrey D. Dunn, PharmD, MBA: Obviously, if a patient can’t breathe, they’re going to seek help. Or if they have an exacerbation and have to…